Lamivudine treatment for HBV infection following thoracic organ transplantation

Transplant Proc. 2001 Feb-Mar;33(1-2):1576-8. doi: 10.1016/s0041-1345(00)02599-9.

Authors

P Grossi¹, D Dalla Gasperina, M Furione, M Viganò, L Minoli

Affiliation

¹ Dipartimento di Medicina e Sanita Pubblica, Universitá degli Studi dell'Insubria, Varese, Italy.

PMID: 11267426
DOI: 10.1016/s0041-1345(00)02599-9

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Biopsy
Child
Female
Heart Transplantation* / pathology
Heart-Lung Transplantation / pathology
Hepatitis B, Chronic / drug therapy*
Hepatitis B, Chronic / epidemiology
Humans
Lamivudine / adverse effects
Lamivudine / therapeutic use*
Liver / pathology
Lung Transplantation* / pathology
Male
Middle Aged
Postoperative Complications / drug therapy*
Postoperative Complications / epidemiology
Prevalence
Reverse Transcriptase Inhibitors / adverse effects
Reverse Transcriptase Inhibitors / therapeutic use*

Substances

Reverse Transcriptase Inhibitors
Lamivudine